Ulotaront: A TAAR1 Agonist for the Treatment of Schizophrenia
Author:
Affiliation:
1. Sunovion Pharmaceuticals Inc, Marlborough, Massachusetts 01752, United States
Funder
Sunovion
Publisher
American Chemical Society (ACS)
Subject
Organic Chemistry,Drug Discovery,Biochemistry
Link
https://pubs.acs.org/doi/pdf/10.1021/acsmedchemlett.1c00527
Reference53 articles.
1. Safety and Effectiveness of SEP−363856 in Schizophrenia: Results of a 6-Month, Open-Label Extension Study
2. A Non–D2-Receptor-Binding Drug for the Treatment of Schizophrenia
3. Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs
4. SEP-363856, a Novel Psychotropic Agent with a Unique, Non-D2 Receptor Mechanism of Action
5. Towards Novel Treatments for Schizophrenia: Molecular and Behavioural Signatures of the Psychotropic Agent SEP-363856
Cited by 30 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. TAAR1 agonists improve glycemic control, reduce body weight and modulate neurocircuits governing energy balance and feeding;Molecular Metabolism;2024-02
2. Molecular basis of human trace amine-associated receptor 1 activation;Nature Communications;2024-01-02
3. Recognition of methamphetamine and other amines by trace amine receptor TAAR1;Nature;2023-11-07
4. Collective and Coordinated Conformational Changes Determine Agonism or Antagonism at the Human Trace Amine-Associated Receptor 1;ACS Omega;2023-10-31
5. A Phase I, Open-Label, Fixed Sequence Study to Investigate the Effect of Cytochrome P450 2D6 Inhibition on the Pharmacokinetics of Ulotaront in Healthy Subjects;Clinical Pharmacokinetics;2023-10-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3